Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Bateman

Showing results (11-20 of 161) with videos related to

Pageof 17
Sort By:
Pulmonary Pharmacology & Therapeutics|March 30, 2013
Pharmacodynamics of GSK961081, a bi-functional molecule, in patients with COPDEric D Bateman, Oliver Kornmann, Claire Ambery, et al.
The Lancet. Respiratory Medicine|May 14, 2015
Tiotropium in asthma - Authors' replyHuib A M Kerstjens, Petra Moroni-Zentgraf, Eric D Bateman
Respiratory Medicine|October 18, 2005
Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control QuestionnaireElizabeth F Juniper, Jean Bousquet, Linda Abetz, et al.
Respiratory Research|March 23, 2007
Validation of a guideline-based composite outcome assessment tool for asthma controlSally Spencer, Bhabita Mayer, Kate L Bendall, et al.
The Journal of Allergy and Clinical Immunology|February 27, 2016
Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthmaEric D Bateman, Udo-Michael Goehring, Frank Richard, et al.
The European Respiratory Journal|February 25, 2022
Asthma management in low and middle income countries: case for changeKevin Mortimer, Helen K Reddel, Paulo M Pitrez, et al.
Respirology (Carlton, Vic.)|April 3, 2020
What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?Christine R Jenkins, Eric D Bateman, Malcolm R Sears, et al.
Applied Health Economics and Health Policy|January 28, 2016
Erratum to: Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-AgonistsJenny Willson, Eric D Bateman, Ian Pavord, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2006
Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped downEric D Bateman, Loretta Jacques, Caroline Goldfrad, et al.
Drug Design, Development and Therapy|May 17, 2018
Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β<sub>2</sub>-agonists in patients with atopic asthmaEric D Bateman, Christopher O'Brien, Paul Rugman, et al.
Pageof 17

Showing results (11-20 of 161) with videos related to

Sort By:
Pageof 17
Pulmonary Pharmacology & Therapeutics|March 30, 2013
Pharmacodynamics of GSK961081, a bi-functional molecule, in patients with COPDEric D Bateman, Oliver Kornmann, Claire Ambery, et al.
The Lancet. Respiratory Medicine|May 14, 2015
Tiotropium in asthma - Authors' replyHuib A M Kerstjens, Petra Moroni-Zentgraf, Eric D Bateman
Respiratory Medicine|October 18, 2005
Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control QuestionnaireElizabeth F Juniper, Jean Bousquet, Linda Abetz, et al.
Respiratory Research|March 23, 2007
Validation of a guideline-based composite outcome assessment tool for asthma controlSally Spencer, Bhabita Mayer, Kate L Bendall, et al.
The Journal of Allergy and Clinical Immunology|February 27, 2016
Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthmaEric D Bateman, Udo-Michael Goehring, Frank Richard, et al.
The European Respiratory Journal|February 25, 2022
Asthma management in low and middle income countries: case for changeKevin Mortimer, Helen K Reddel, Paulo M Pitrez, et al.
Respirology (Carlton, Vic.)|April 3, 2020
What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?Christine R Jenkins, Eric D Bateman, Malcolm R Sears, et al.
Applied Health Economics and Health Policy|January 28, 2016
Erratum to: Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-AgonistsJenny Willson, Eric D Bateman, Ian Pavord, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2006
Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped downEric D Bateman, Loretta Jacques, Caroline Goldfrad, et al.
Drug Design, Development and Therapy|May 17, 2018
Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β<sub>2</sub>-agonists in patients with atopic asthmaEric D Bateman, Christopher O'Brien, Paul Rugman, et al.
Pageof 17